NasdaqGS - Nasdaq Real Time Price USD
Inhibrx Biosciences, Inc. (INBX)
12.26
+0.28
+(2.34%)
At close: April 25 at 4:00:02 PM EDT
12.58
+0.32
+(2.61%)
Pre-Market: 6:14:40 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Operating Cash Flow
-194,409
-194,409
-193,309
-90,811
Investing Cash Flow
-2,597
-2,597
-4,593
-686
Financing Cash Flow
71,678
71,678
201,961
91,497
End Cash Position
152,596
152,596
277,924
--
Income Tax Paid Supplemental Data
2
2
3
4
Interest Paid Supplemental Data
11,506
11,506
26,717
--
Capital Expenditure
-2,597
-2,597
-4,593
-686
Issuance of Capital Stock
--
--
200,000
--
Free Cash Flow
-197,006
-197,006
-197,902
-91,497
12/31/2022 - 6/4/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ROIV Roivant Sciences Ltd.
11.01
+0.09%
ITOS iTeos Therapeutics, Inc.
7.35
-1.47%
PBYI Puma Biotechnology, Inc.
3.0000
-0.33%
KROS Keros Therapeutics, Inc.
14.21
-1.46%
KYMR Kymera Therapeutics, Inc.
33.26
-0.89%
IPHA Innate Pharma S.A.
1.9800
0.00%
HRMY Harmony Biosciences Holdings, Inc.
29.61
+0.61%
ORIC ORIC Pharmaceuticals, Inc.
5.10
-1.73%
RIGL Rigel Pharmaceuticals, Inc.
19.28
+1.15%
PBN.F Alterity Therapeutics Limited
0.0045
0.00%